受强制性开放获取政策约束的文章 - Nilesh Gupta了解详情
可在其他位置公开访问的文章：9 篇
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension
V Gupta, N Gupta, IH Shaik, R Mehvar, IF McMurtry, M Oka, ...
Journal of controlled release 167 (2), 189-199, 2013
强制性开放获取政策： US National Institutes of Health
Nano-engineered erythrocyte ghosts as inhalational carriers for delivery of fasudil: preparation and characterization
N Gupta, B Patel, F Ahsan
Pharmaceutical Research 31 (6), 1553-65, 2014
强制性开放获取政策： US National Institutes of Health
Fasudil and SOD packaged in peptide-studded-liposomes: properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs
N Gupta, FI Al-Saikhan, B Patel, J Rashid, F Ahsan
International journal of pharmaceutics 488 (1-2), 33-43, 2015
强制性开放获取政策： US National Institutes of Health
Peptide-coated liposomal fasudil enhances site specific vasodilation in pulmonary arterial hypertension
K Nahar, S Absar, N Gupta, VR Kotamraju, IF McMurtry, M Oka, ...
Molecular pharmaceutics 11 (12), 4374-4384, 2014
强制性开放获取政策： US National Institutes of Health
Peptide–micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension
N Gupta, HM Ibrahim, F Ahsan
Journal of Pharmaceutical Sciences 103 (11), 3743-3753, 2014
强制性开放获取政策： US National Institutes of Health
Cell permeable peptide conjugated nanoerythrosomes of fasudil prolong pulmonary arterial vasodilation in PAH rats
N Gupta, B Patel, K Nahar, F Ahsan
European Journal of Pharmaceutics and Biopharmaceutics 88 (3), 1046-1055, 2014
强制性开放获取政策： US National Institutes of Health
Inhaled PLGA Particles of Prostaglandin E1 Ameliorate Symptoms and Progression of Pulmonary Hypertension at a Reduced Dosing Frequency
V Gupta, N Gupta, IH Shaik, R Mehvar, E Nozik-Grayck, IF McMurtry, ...
Molecular pharmaceutics 10 (5), 1655-1667, 2013
强制性开放获取政策： US National Institutes of Health
Cocktail of superoxide dismutase and fasudil encapsulated in targeted liposomes slows PAH progression at a reduced dosing frequency
N Gupta, J Rashid, E Nozik-Grayck, IF McMurtry, KR Stenmark, F Ahsan
Molecular pharmaceutics 14 (3), 830-841, 2017
强制性开放获取政策： US National Institutes of Health
Low-molecular-weight heparin (LMWH)–loaded large porous PEG-PLGA particles for the treatment of asthma
B Patel, N Gupta, F Ahsan
Journal of aerosol medicine and pulmonary drug delivery 27 (1), 12-20, 2014
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定